Vaneck Vectors Pharmaceutical etf shares owned by Citigroup
Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Vaneck Vectors Pharmaceutical etf
Tip: Access up to 7 years of quarterly data
All positions including Vaneck Vectors Pharmaceutical etf held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $23M | 220k | 103.88 |
| 2024-12-31 | $36k | 413 | 86.28 |
| 2024-06-30 | $18k | 200 | 91.48 |
| 2024-03-31 | $18k | 200 | 90.72 |
| 2023-12-31 | $16k | 200 | 81.37 |
| 2023-09-30 | $16k | 200 | 79.86 |
| 2023-03-31 | $240k | 3.1k | 77.63 |
| 2022-12-31 | $102k | 1.3k | 77.74 |
| 2022-09-30 | $13k | 200 | 65.00 |
| 2021-12-31 | $15k | 200 | 75.00 |
| 2021-03-31 | $30k | 435 | 68.97 |
| 2020-12-31 | $29k | 435 | 66.67 |
| 2020-09-30 | $27k | 435 | 62.07 |
| 2020-06-30 | $27k | 437 | 61.78 |
| 2020-03-31 | $18k | 337 | 53.41 |
| 2019-12-31 | $22k | 337 | 65.28 |
| 2019-09-30 | $19k | 337 | 56.38 |
| 2019-06-30 | $20k | 337 | 59.35 |
| 2019-03-31 | $20k | 337 | 59.35 |
| 2018-12-31 | $19k | 337 | 56.38 |
| 2018-09-30 | $13M | 200k | 64.34 |
| 2018-06-30 | $12M | 200k | 59.00 |
| 2018-03-31 | $12M | 218k | 56.68 |
| 2017-12-31 | $13M | 218k | 59.39 |
| 2017-09-30 | $12M | 200k | 57.76 |
| 2017-06-30 | $12M | 200k | 59.10 |
| 2017-03-31 | $30M | 551k | 55.14 |
| 2016-12-31 | $18M | 351k | 52.51 |
| 2016-09-30 | $37M | 651k | 57.46 |
| 2016-06-30 | $44k | 755 | 58.28 |
Top funds holding Vaneck Vectors Pharmaceutical etf
View all funds holding Vaneck Vectors Pharmaceutical etf